Nabriva Therapeutics PLC
(FRA:NTY)
€
0.665
0.065 (10.83%)
Market Cap: 1.90 Mil
Enterprise Value: 753,000.00
PE Ratio: 0
PB Ratio: 0
GF Score: 27/100 Nabriva Therapeutics PLC (FRA:NTY) Transcripts
- Q3 2022 Nabriva Therapeutics PLC Earnings Call TranscriptNov 10, 2022€2.2 (-3.51%)Earnings
- Q2 2022 Nabriva Therapeutics PLC Earnings Call TranscriptAug 03, 2022€4.53 (+11.73%)Earnings
- Q1 2022 Nabriva Therapeutics PLC Earnings Call TranscriptMay 05, 2022€7.05 (+2.92%)Earnings
- Q4 2021 Nabriva Therapeutics PLC Earnings Call TranscriptMar 29, 2022€10.5 (-1.87%)Earnings
- Q3 2021 Nabriva Therapeutics PLC Earnings Call TranscriptNov 09, 2021€27.5Earnings
- Q2 2021 Nabriva Therapeutics PLC Earnings Call TranscriptAug 05, 2021€25.25 (-1.94%)Earnings
- Q1 2021 Nabriva Therapeutics PLC Earnings Call TranscriptMay 06, 2021€32.5 (-5.11%)Earnings
- Q4 2020 Nabriva Therapeutics PLC Earnings Call TranscriptMar 11, 2021€36.5 (-1.35%)Earnings
- Q3 2020 Nabriva Therapeutics PLC Earnings Call TranscriptNov 05, 2020€100 (+0.03%)Earnings
- Q2 2020 Nabriva Therapeutics PLC Earnings Call TranscriptAug 06, 2020€168 (+1.51%)Earnings
- Nabriva Therapeutics PLC at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 13, 2020
- Q1 2020 Nabriva Therapeutics PLC Earnings Call TranscriptMay 11, 2020€151.25 (+17.48%)Earnings
- Q4 2019 Nabriva Therapeutics PLC Earnings Call TranscriptMar 12, 2020€237.5 (-12.04%)Earnings
- Q3 2019 Nabriva Therapeutics PLC Earnings Call TranscriptNov 12, 2019€445Earnings
- Nabriva Therapeutics PLC at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Nabriva Therapeutics plc - Special Call TranscriptAug 19, 2019
- Nabriva Therapeutics PLC at Bank of America Merrill Lynch Health Care Conference TranscriptMay 15, 2019
- Nabriva Therapeutics plc Complete Response Letter from FDA on NDA Conference Call TranscriptMay 01, 2019
- 1